Saturday, July 11, 2026

Drug profile · INN

asacol

asacol is a arachidonate 5-lipoxygenase inhibitor.

NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — asacol
Class
Route
Patents
0
Programs
0
Data quality
0.70

Quick answer

asacol is a arachidonate 5-lipoxygenase inhibitor.

Key facts

INN asacol
Mechanism Arachidonate 5-lipoxygenase inhibitor
Target Polyunsaturated fatty acid 5-lipoxygenase

Mechanism of action

Arachidonate 5-lipoxygenase inhibitor

Primary target: Polyunsaturated fatty acid 5-lipoxygenase

Approval history

Authority Status Date
NMPA clinical trials

Related & competitor drugs

  1. meclofenamate sodium Arachidonate 5-lipoxygenase inhibitor
  2. mesalamine Arachidonate 5-lipoxygenase inhibitor
  3. zileuton Arachidonate 5-lipoxygenase inhibitor
  4. balsalazide disodium Cyclooxygenase inhibitor
  5. olsalazine sodium Arachidonate 5-lipoxygenase inhibitor
  6. sulfasalazine Arachidonate 5-lipoxygenase inhibitor

Frequently asked questions

What is asacol?

asacol is a arachidonate 5-lipoxygenase inhibitor.